Literature DB >> 6458607

Liberation of N-acetylglucosamine-6-sulfate by human beta-N-acetylhexosaminidase A.

H Kresse, W Fuchs, J Glössl, D Holtfrerich, W Gilberg.   

Abstract

The first step of the degradation of p-nitrophenyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyranoside and of keratan sulfate-derived oligosaccharides bearing N-acetylglucosamine-6-sulfate residues at the nonreducing end was considered to be accomplished by the action of a specific sulfatase (Kresse, H., Paschke, E., von Figura, K., Gilberg, W., and Fuchs W. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 6822-6826). In purification from human placenta, however, this activity co-chromatographed with isoenzyme A of beta-N-acetylhexosaminidase and had the same electrophoretic mobility as the latter enzyme. The activity was precipitated by a specific antiserum against beta-N-acetylhexosaminidase. A pronounced enzyme deficiency was found in Tay-Sachs and Sandhoff fibroblasts. The purified enzyme released p-nitrophenol from the chromogenic substrate as well as a second product which contained equimolar amounts of hexosamine and sulfate. This product had the same electrophoretic and chromatographic behavior as sulfated N-acetylglucosamine. It could be degraded by periodate to a smaller charged fragment. Incubation of keratan sulfate-derived oligosaccharides with beta-N-acetylhexosaminidase A analogously resulted in the liberation of N-acetylglucosamine-6-sulfate. The enzyme showed the highest affinity towards a trisulfated tetrasaccharide and exhibited a similar Km for the sulfated and the unsulfated p-nitrophenyl derivative.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6458607

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Towards quality assurance in the determination of lysosomal enzymes: a two-centre study.

Authors:  Z Lukacs; A Keil; V Peters; A Kohlschütter; G F Hoffmann; M Cantz; J Kopitz
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

2.  Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease.

Authors:  P Leinekugel; S Michel; E Conzelmann; K Sandhoff
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

3.  A novel mechanism for desulfation of mucin: identification and cloning of a mucin-desulfating glycosidase (sulfoglycosidase) from Prevotella strain RS2.

Authors:  Jung-hyun Rho; Damian P Wright; David L Christie; Keith Clinch; Richard H Furneaux; Anthony M Roberton
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

4.  Hexosaminidase assays.

Authors:  Michaela Wendeler; Konrad Sandhoff
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

5.  Diagnosis and carrier detection of Tay-Sachs disease: direct determination of hexosaminidase A using 4-methylumbelliferyl derivatives of beta-N-acetylglucosamine-6-sulfate and beta-N-acetylgalactosamine-6-sulfate.

Authors:  Y Ben-Yoseph; J E Reid; B Shapiro; H L Nadler
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

6.  A possible biomarker of neurocytolysis in infantile gangliosidoses: aspartate transaminase.

Authors:  Mustafa Kılıç; Çiğdem Seher Kasapkara; Sebile Kılavuz; Neslihan Önenli Mungan; Gürsel Biberoğlu
Journal:  Metab Brain Dis       Date:  2019-02-02       Impact factor: 3.584

7.  Metabolomics profiling reveals profound metabolic impairments in mice and patients with Sandhoff disease.

Authors:  Li Ou; Michael J Przybilla; Chester B Whitley
Journal:  Mol Genet Metab       Date:  2018-09-14       Impact factor: 4.797

8.  Diagnosis of infantile and juvenile forms of GM2 gangliosidosis variant 0. Residual activities toward natural and different synthetic substrates.

Authors:  H J Kytzia; U Hinrichs; K Sandhoff
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

9.  Occurrence of reducing terminal N-acetylglucosamine 3-sulfate and fucosylated outer chains in acidic N-glycans of porcine zona pellucida glycoproteins.

Authors:  E Mori; J L Hedrick; N J Wardrip; T Mori; S Takasaki
Journal:  Glycoconj J       Date:  1998-05       Impact factor: 2.916

10.  Clinical heterogeneity in Sanfilippo disease (mucopolysaccharidosis III) type D: presentation of two new cases.

Authors:  G V Coppa; P L Giorgi; L Felici; O Gabrielli; E Donti; S Bernasconi; H Kresse; E Paschke; C Mastropaolo
Journal:  Eur J Pediatr       Date:  1983-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.